Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension
Felix Mahfoud(University of Basel), Michael Böhm(Saarland University), Mathias C. Brandt(Baker Heart and Diabetes Institute), Murray Esler(Baker Heart and Diabetes Institute), Ingrid Kindermann(Baker Heart and Diabetes Institute), Bodo Cremers(Baker Heart and Diabetes Institute), Uta C. Hoppe(Baker Heart and Diabetes Institute), Markus P. Schlaich(The University of Western Australia), Lars Christian Rump(Düsseldorf University Hospital), Christian Ukena(Baker Heart and Diabetes Institute), Paul A. Sobotka(The Ohio State University), Henry Krum(Australian Regenerative Medicine Institute), Oliver Vonend(Baker Heart and Diabetes Institute)
Cited by 569
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k